ProfileGDS5678 / 1416066_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 96% 96% 97% 95% 96% 97% 96% 97% 97% 97% 97% 97% 97% 97% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 18.9641196
GSM967853U87-EV human glioblastoma xenograft - Control 28.9303696
GSM967854U87-EV human glioblastoma xenograft - Control 39.1942697
GSM967855U87-EV human glioblastoma xenograft - Control 48.668795
GSM967856U87-EV human glioblastoma xenograft - Control 59.0984896
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 19.095797
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 28.7891896
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 39.2110897
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 49.5942697
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 19.36597
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 29.3266397
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 39.3698297
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 49.5335797
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 59.4665297